Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Sakon

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
International Journal of Oncology|January 14, 2004
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinomaTaro Aoki, Atsushi Miyamoto, Shigeru Marubashi, et al.
Cancer|March 20, 2002
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branchesMasato Sakon, Hiroaki Nagano, Keizo Dono, et al.
Oncology|August 21, 2014
Diagnostic laparoscopy with 5-aminolevulinic-acid-mediated photodynamic diagnosis enhances the detection of peritoneal micrometastases in advanced gastric cancerKentaro Kishi, Yoshiyuki Fujiwara, Masahiko Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of hemobilia developing after radiofrequency ablation (RFA) for hepatocellular carcinoma]Shinya Yamashita, Masato Sakon, Itsuro Souma, et al.
Liver|May 25, 2002
Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinomaYasuhiro Ito, Tsutomu Takeda, Yo Sasaki, et al.
Cancer|October 18, 2007
Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodulesHiroaki Nagano, Atsushi Miyamoto, Hiroshi Wada, et al.
Japanese Journal of Clinical Oncology|July 21, 2006
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancerMasanori Tsujie, Shoji Nakamori, Eiichi Tanaka, et al.
Hepato-Gastroenterology|May 17, 2003
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinomaMotoi Kondo, Hiroaki Nagano, Masato Sakon, et al.
General Thoracic and Cardiovascular Surgery|June 7, 2017
Is <sup>18</sup>F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?Keijiro Sugimura, Hiroshi Miyata, Masahiko Yano, et al.
Oncology Letters|January 2, 2016
Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acidMasaaki Motoori, Masahiko Yano, Koji Tanaka, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
International Journal of Oncology|January 14, 2004
Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinomaTaro Aoki, Atsushi Miyamoto, Shigeru Marubashi, et al.
Cancer|March 20, 2002
Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branchesMasato Sakon, Hiroaki Nagano, Keizo Dono, et al.
Oncology|August 21, 2014
Diagnostic laparoscopy with 5-aminolevulinic-acid-mediated photodynamic diagnosis enhances the detection of peritoneal micrometastases in advanced gastric cancerKentaro Kishi, Yoshiyuki Fujiwara, Masahiko Yano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of hemobilia developing after radiofrequency ablation (RFA) for hepatocellular carcinoma]Shinya Yamashita, Masato Sakon, Itsuro Souma, et al.
Liver|May 25, 2002
Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinomaYasuhiro Ito, Tsutomu Takeda, Yo Sasaki, et al.
Cancer|October 18, 2007
Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodulesHiroaki Nagano, Atsushi Miyamoto, Hiroshi Wada, et al.
Japanese Journal of Clinical Oncology|July 21, 2006
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancerMasanori Tsujie, Shoji Nakamori, Eiichi Tanaka, et al.
Hepato-Gastroenterology|May 17, 2003
The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinomaMotoi Kondo, Hiroaki Nagano, Masato Sakon, et al.
General Thoracic and Cardiovascular Surgery|June 7, 2017
Is <sup>18</sup>F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?Keijiro Sugimura, Hiroshi Miyata, Masahiko Yano, et al.
Oncology Letters|January 2, 2016
Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acidMasaaki Motoori, Masahiko Yano, Koji Tanaka, et al.
Pageof 22